Zimmer Biomet Denmark ApS: Financial statements 2012
CVR: 33051441
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Zimmer Biomet Denmark ApS (CVR 33051441) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 81,533,431 and a net result of DKK 1,800,799. The profit margin was 2.2%. Equity in the 2012 report amounted to DKK 3,223,419. The solvency ratio was 7.6%.
- Revenue
- DKK 81,533,431
- Gross Profit
- DKK 15,186,531
- Profit/Loss
- DKK 1,800,799
- Equity
- DKK 3,223,419
- Total Assets
- DKK 42,291,837
Official annual report
Keep an eye on Zimmer Biomet Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of November 20, 2012, Michael Persson is registered as director of Zimmer Biomet Denmark ApS.
As of November 20, 2012, Hans Gustav Teslow Naess has stepped down as director of Zimmer Biomet Denmark ApS.
About Zimmer Biomet Denmark ApS
Zimmer Biomet Denmark ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ZIMMER DENMARK ApS and KR 1625 ApS. The management consists of Jenny Madelene Stokke, Alan Lentz Wiese and Claire Lisa Savine. The company is owned by Zimmer GmbH. The company has 36 employees (2026). In 2025, the company reported a gross profit of DKK 62,604,682 and a net result of DKK 18,383,359 compared with DKK 16,267,254 the year before. Equity in the 2025 report amounted to DKK 127,046,174.